EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma.
| Image |  |
|---|---|
| Description | scientific article published on 6 September 2017 |
| Author/s |
author: Timothy D Clay |
| Publication date | September 6, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |